Little Green Pharma (LGP) has announced delivery of its first shipment of medicinal cannabis oils into the French national medicinal cannabis trial.

The shipment is scheduled to be release tested in France and made available to trial patients later this month.

In January, LGP was appointed as a primary supplier to the trial in partnership with French pharmaceutical distributor Intsel Chimos.

The trial is being conducted by the French National Agency for the Safety of Medicines and Health Products and will be the only lawful source of medicinal cannabis in France until it ends in early 2023.

It is hoped it will be a catalyst for the legalisation of medicinal cannabis in
France.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...